Company Performance Metrics
Cambridge Genetics develops bioinformatics software for local-first, artificial intelligence-powered genetic health reporting. The company focuses on secure, decentralized genomic analysis tools that run directly on standard workstations rather than relying on cloud infrastructure. Its products include clinical-grade imputation engines that convert
microarray data into pseudo whole-genome coverage, as well as polygenic risk score calculators for assessing complex genetic risk. Cambridge Genetics also offers machine learning variant classifiers that support genome-wide association studies, variant interpretation, and pharmacogenomics. These tools are designed for researchers, clinicians, and bioinformaticians who require high-throughput genomic analysis within local computing environments. The company concentrates on the intersection of genetics and machine learning to provide computational infrastructure for biomedical science workflows.